Analysis of bacterial genes may help ID cause of dog brain disease, researchers say

Sep 28, 2012
Dan Brown, an associate professor in the department of infectious diseases and pathology, and bioscientist Dina Michaels use a fluorescence microscope to analyze cells of the canine immune system during infection with Mycoplasma canis.

(Phys.org)—By analyzing the genes of bacteria, University of Florida researchers have moved a step closer to pinpointing how two brain disorders common in small-breed dogs occur.

The researchers found that the , known as Mycoplasma canis, invade dog's cells and suppress their .

"This could explain how the bacteria are able to enter the in certain circumstances," said lead investigator Daniel Brown, an associate professor of infectious diseases at the UF College of Veterinary Medicine. "If our theory is correct, it is possible that antibiotic therapy aimed at the mycoplasma could be beneficial if the condition is diagnosed early enough."

The findings, which appear in the August issue of the Journal of Bacteriology, were also presented at the annual meeting of the International Organization for Mycoplasmology in France.

The researchers studied two common brain syndromes called granulomatous meningoencephalomyelitis, or GME, and necrotizing meningoencephalitis, or NME, which occur primarily in small toy-breed dogs such as pugs, Malteses, Yorkshire terriers, Chihuahuas and Pomeranians. The diseases affect the central nervous system, causing and symptoms such as seizures, decreased alertness and difficulty maintaining balance. There is no cure, but drugs can control the by suppressing the immune system.

No clear data exist on how widespread the disorders are.

"Although reliable information on new and existing cases is pretty scarce or nonexistent, inflammatory disease is certainly one of the most common problems we deal with as veterinary neurologists," said Christopher Mariani, D.V.M., Ph.D., an assistant professor of neurology at North Carolina State University's College of Veterinary Medicine. Mariana was not involved in the UF study.

The syndromes previously were thought to be caused by a virus or by an attack of the body's own immune system. But University of Georgia researchers Renee Barber, and Scott Schatzberg, and colleagues, including Brown, reported earlier this year that whereas viruses were absent from the brain tissues of dogs with the diseases, the bacterium Mycoplasma canis was unexpectedly common. Interestingly, the researchers also found traces of the bacteria in some dogs that did not have the disease.

The bacteria would not have been detected by the methods used previously to search for a presumed viral agent.

In the new study, Brown and colleagues examined five strains of Mycoplasma canis isolated from three different parts of the body—the brain, the genital tract and the throat.

They found no difference between the genetic makeup of the bacteria from brain tissue and that of the bacteria from other sites.

What they did find was evidence that the bacteria don't just sit on the surfaces of cells, but actually penetrate inside cells. That may be what enables entry into the bloodstream and eventually, to the brain, the researchers said.

"This finding is tantalizing, because it may offer an explanation as to why scientists have never been able to specify a viral, autoimmune or other cause of GME and NME," Brown said.

In addition, different strains of bacteria were not equally efficient at suppressing the dogs' immune responses.

The researchers are continuing to analyze the effects of bacterial infection on cells known as macrophages to determine how the bacteria could breach the blood-brain barrier. Later, they will extend their studies to examining how the bacteria interact with different types of brain cells.

"The study is intriguing, but more work needs to be completed to determine the significance of these bacteria as a possible cause of GME and NME," said Karen Vernau, an associate clinical professor and chief of neurology/neurosurgery at the University of California, Davis' College of , who was not involved in the study.

Explore further: Earliest stages of ear development involve a localized signaling cascade

add to favorites email to friend print save as pdf

Related Stories

Brain structure assists in immune response (Video)

Jan 28, 2009

For the first time, a team of researchers at the University of Pennsylvania School of Veterinary Medicine have imaged in real time the body's immune response to a parasitic infection in the brain.

Brothers in arms: Commensal bacteria help fight viruses

Jun 18, 2012

Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways – from helping digest ...

Receptor may hold key to multiple sclerosis treatment

Jun 11, 2012

(Medical Xpress) -- A receptor recently discovered to control the movement of immune cells across central nervous system barriers (including the blood-brain barrier) may hold the key to treating multiple sclerosis ...

Recommended for you

Genomes of malaria-carrying mosquitoes sequenced

Nov 27, 2014

Nora Besansky, O'Hara Professor of Biological Sciences at the University of Notre Dame and a member of the University's Eck Institute for Global Health, has led an international team of scientists in sequencing ...

How calcium regulates mitochondrial carrier proteins

Nov 26, 2014

Mitochondrial carriers are a family of proteins that play the key role of transporting a chemically diverse range of molecules across the inner mitochondrial membrane. Mitochondrial aspartate/glutamate carriers are part of ...

Team conducts unprecedented analysis of microbial ecosystem

Nov 26, 2014

An international team of scientists from the Translational Genomics Research Institute (TGen) and The Luxembourg Centre for Systems Biomedicine (LCSB) have completed a first-of-its-kind microbial analysis of a biological ...

Students create microbe to weaken superbug

Nov 25, 2014

A team of undergraduate students from the University of Waterloo have designed a synthetic organism that may one day help doctors treat MRSA, an antibiotic-resistant superbug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.